Delivery Order SPE2DB22D2108-SPE2DB24FU4GU

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,081.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of the TWINRIX VACCINE SYRINGEML. The contract is a Firm Fixed Price Delivery Order with a completion date of February 6, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, particularly within military and veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,438.37, is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,595.00 firm fixed-price delivery order is for the procurement of TWINRIX VACCINE SYRINGEML, with a period of performance through April 10, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of TWINRIX VACCINE SYRINGEML. The $2,156.48 firm fixed-price delivery order has an ultimate completion date of January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Twinrix vaccine syringes. The contract is a delivery order with a firm fixed price valued at $10,660.48 and has an ultimate completion date of August 23, 2024. The contract is not set aside for any specific business size or socioeconomic category. AmerisourceBergen has been awarded multiple indefinite delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TWINRIX vaccine syringes. The contract has a ceiling value of $6,308.31 and runs through October 17, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC provides a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,911.40, is for the delivery of TWINRIX vaccine syringes. It is a firm-fixed-price delivery order contract that runs through March 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $45,854.55, is for the delivery of TWINRIX VACCINE SYRINGEML, a medical vaccine product. The contract is a Firm Fixed Price Delivery Order with a period of performance extending through May 12, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $98,326.08 firm fixed-price delivery order is for the supply of TWINRIX vaccine syringes. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of TWINRIX VACCINE SYRINGEML. The award has a ceiling value of $14,927.78 and an ultimate completion date of August 20, 2024. The contract is a Firm Fixed Price type. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4GU
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the purchase of TWINRIX VACCINE SYRINGEML. The contract has a ceiling value of $2,731.28 and is a Firm Fixed Price Delivery Order with a period of performance through June 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:48 AM